Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

SKU ID : QYR-21744866 | Publishing Date : 20-Sep-2022 | No. of pages : 115

Detailed TOC of Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

1 Report Overview
    1.1 Research Scope
    1.2 Market Segment by Type
        1.2.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
        1.2.2 Diuretics
        1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
        1.2.4 Angiotensin Receptor Blockers (ARBs)
        1.2.5 Calcium Channel Blockers
        1.2.6 Beta Blockers
        1.2.7 Alpha Blockers
        1.2.8 Vasodilators
        1.2.9 Renin Inhibitors
    1.3 Market Segment by Application
        1.3.1 Global Anti-Hypertensive Drugs Market Share by Application (2017 VS 2021 VS 2028)
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Market Perspective
    2.1 Global Anti-Hypertensive Drugs Market Size (2017-2028)
        2.1.1 Global Anti-Hypertensive Drugs Revenue (2017-2028)
        2.1.2 Global Anti-Hypertensive Drugs Sales (2017-2028)
    2.2 Global Anti-Hypertensive Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
        2.2.1 Global Anti-Hypertensive Drugs Sales by Regions (2017-2022)
        2.2.2 Global Anti-Hypertensive Drugs Revenue by Regions (2017-2022)
    2.3 Global Anti-Hypertensive Drugs Market Size Forecast by Region
        2.3.1 Global Anti-Hypertensive Drugs Sales Forecast by Region (2023-2028)
        2.3.2 Global Anti-Hypertensive Drugs Revenue Forecast by Region (2023-2028)
    2.4 Global Top Anti-Hypertensive Drugs Regions (Countries) Ranking by Market Size
    2.5 Anti-Hypertensive Drugs  Market Dynamics
        2.5.1 Anti-Hypertensive Drugs Market Trends
        2.5.2 Anti-Hypertensive Drugs Market Drivers
        2.5.3 Anti-Hypertensive Drugs Market Challenges
        2.5.4 Anti-Hypertensive Drugs Market Restraints
3 Competitive Landscape by Manufacturers
    3.1 Global Top Anti-Hypertensive Drugs Manufacturers by Sales (2017-2022)
        3.1.1 Global Anti-Hypertensive Drugs Sales by Manufacturers (2017-2022)
        3.1.2 Global Anti-Hypertensive Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global 5 and 10 Largest Manufacturers by Anti-Hypertensive Drugs Sales in 2021
    3.2 Global Top Manufacturers Anti-Hypertensive Drugs by Revenue
        3.2.1 Global Anti-Hypertensive Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Top Anti-Hypertensive Drugs Manufacturers Covered: Ranking by Revenue
        3.2.3 Global Anti-Hypertensive Drugs Revenue Share by Manufacturers (2017-2022)
        3.2.4 Global Anti-Hypertensive Drugs Market Concentration Ratio (CR5 and HHI)
    3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Hypertensive Drugs as of 2021)
    3.4 Global Anti-Hypertensive Drugs Average Selling Price (ASP) by Manufacturers
    3.5 Key Manufacturers Anti-Hypertensive Drugs Plants/Factories Distribution and Area Served
    3.6 Date of Key Manufacturers Enter into Anti-Hypertensive Drugs Market
    3.7 Key Manufacturers Anti-Hypertensive Drugs Product Offered
    3.8 Mergers & Acquisitions, Expansion Plans
4 Global Anti-Hypertensive Drugs Market Size by Type
    4.1 Global Anti-Hypertensive Drugs Historic Market Review by Type (2017-2022)
        4.1.1 Global Anti-Hypertensive Drugs Sales Market Share by Type (2017-2022)
        4.1.2 Global Anti-Hypertensive Drugs Revenue Market Share by Type (2017-2022)
        4.1.3 Anti-Hypertensive Drugs Price by Type (2017-2022)
    4.2 Global Anti-Hypertensive Drugs Market Estimates and Forecasts by Type (2023-2028)
        4.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Type (2023-2028)
        4.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Type (2023-2028)
        4.2.3 Anti-Hypertensive Drugs Price Forecast by Type (2023-2028)
5 Global Anti-Hypertensive Drugs Market Size by Application
    5.1 Global Anti-Hypertensive Drugs Historic Market Review by Application (2017-2022)
        5.1.1 Global Anti-Hypertensive Drugs Sales Market Share by Application (2017-2022)
        5.1.2 Global Anti-Hypertensive Drugs Revenue Market Share by Application (2017-2022)
        5.1.3 Anti-Hypertensive Drugs Price by Application (2017-2022)
    5.2 Global Anti-Hypertensive Drugs Market Estimates and Forecasts by Application (2023-2028)
        5.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Application (2023-2028)
        5.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Application (2023-2028)
        5.2.3 Anti-Hypertensive Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Anti-Hypertensive Drugs Sales Breakdown by Company
        6.1.1 North America Anti-Hypertensive Drugs Sales by Company (2017-2022)
        6.1.2 North America Anti-Hypertensive Drugs Revenue by Company (2017-2022)
    6.2 North America Anti-Hypertensive Drugs Market Size by Type
        6.2.1 North America Anti-Hypertensive Drugs Sales by Type (2017-2028)
        6.2.2 North America Anti-Hypertensive Drugs Revenue by Type (2017-2028)
    6.3 North America Anti-Hypertensive Drugs Market Size by Application
        6.3.1 North America Anti-Hypertensive Drugs Sales by Application (2017-2028)
        6.3.2 North America Anti-Hypertensive Drugs Revenue by Application (2017-2028)
    6.4 North America Anti-Hypertensive Drugs Market Size by Country
        6.4.1 North America Anti-Hypertensive Drugs Sales by Country (2017-2028)
        6.4.2 North America Anti-Hypertensive Drugs Revenue by Country (2017-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Anti-Hypertensive Drugs Sales Breakdown by Company
        7.1.1 Europe Anti-Hypertensive Drugs Sales by Company (2017-2022)
        7.1.2 Europe Anti-Hypertensive Drugs Revenue by Company (2017-2022)
    7.2 Europe Anti-Hypertensive Drugs Market Size by Type
        7.2.1 Europe Anti-Hypertensive Drugs Sales by Type (2017-2028)
        7.2.2 Europe Anti-Hypertensive Drugs Revenue by Type (2017-2028)
    7.3 Europe Anti-Hypertensive Drugs Market Size by Application
        7.3.1 Europe Anti-Hypertensive Drugs Sales by Application (2017-2028)
        7.3.2 Europe Anti-Hypertensive Drugs Revenue by Application (2017-2028)
    7.4 Europe Anti-Hypertensive Drugs Market Size by Country
        7.4.1 Europe Anti-Hypertensive Drugs Sales by Country (2017-2028)
        7.4.2 Europe Anti-Hypertensive Drugs Revenue by Country (2017-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Anti-Hypertensive Drugs Sales Breakdown by Company
        8.1.1 Asia Pacific Anti-Hypertensive Drugs Sales by Company (2017-2022)
        8.1.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Company (2017-2022)
    8.2 Asia Pacific Anti-Hypertensive Drugs Market Size by Type
        8.2.1 Asia Pacific Anti-Hypertensive Drugs Sales by Type (2017-2028)
        8.2.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Type (2017-2028)
    8.3 Asia Pacific Anti-Hypertensive Drugs Market Size by Application
        8.3.1 Asia Pacific Anti-Hypertensive Drugs Sales by Application (2017-2028)
        8.3.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Application (2017-2028)
    8.4 Asia Pacific Anti-Hypertensive Drugs Market Size by Region
        8.4.1 Asia Pacific Anti-Hypertensive Drugs Sales by Region
        8.4.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Region
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 India
        8.4.7 Australia
        8.4.8 Taiwan
        8.4.9 Indonesia
        8.4.10 Thailand
        8.4.11 Malaysia
        8.4.12 Philippines
        8.4.13 Vietnam
9 Latin America
    9.1 Latin America Anti-Hypertensive Drugs Sales Breakdown by Company
        9.1.1 Latin America Anti-Hypertensive Drugs Sales by Company (2017-2022)
        9.1.2 Latin America Anti-Hypertensive Drugs Revenue by Company (2017-2022)
    9.2 Latin America Anti-Hypertensive Drugs Market Size by Type
        9.2.1 Latin America Anti-Hypertensive Drugs Sales by Type (2017-2028)
        9.2.2 Latin America Anti-Hypertensive Drugs Revenue by Type (2017-2028)
    9.3 Latin America Anti-Hypertensive Drugs Market Size by Application
        9.3.1 Latin America Anti-Hypertensive Drugs Sales by Application (2017-2028)
        9.3.2 Latin America Anti-Hypertensive Drugs Revenue by Application (2017-2028)
    9.4 Latin America Anti-Hypertensive Drugs Market Size by Country
        9.4.1 Latin America Anti-Hypertensive Drugs Sales by Country (2017-2028)
        9.4.2 Latin America Anti-Hypertensive Drugs Revenue by Country (2017-2028)
        9.4.3 Mexico
        9.4.4 Brazil
        9.4.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Anti-Hypertensive Drugs Sales Breakdown by Company
        10.1.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Company (2017-2022)
        10.1.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Company (2017-2022)
    10.2 Middle East and Africa Anti-Hypertensive Drugs Market Size by Type
        10.2.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Type (2017-2028)
        10.2.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Type (2017-2028)
    10.3 Middle East and Africa Anti-Hypertensive Drugs Market Size by Application
        10.3.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Application (2017-2028)
        10.3.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Application (2017-2028)
    10.4 Middle East and Africa Anti-Hypertensive Drugs Market Size by Country
        10.4.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Country (2017-2028)
        10.4.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Country (2017-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 U.A.E
11 Company Profiles
    11.1 Novartis
        11.1.1 Novartis Corporation Information
        11.1.2 Novartis Overview
        11.1.3 Novartis Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.1.4 Novartis Anti-Hypertensive Drugs Products and Services
        11.1.5 Novartis Anti-Hypertensive Drugs SWOT Analysis
        11.1.6 Novartis Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.2.4 Pfizer Anti-Hypertensive Drugs Products and Services
        11.2.5 Pfizer Anti-Hypertensive Drugs SWOT Analysis
        11.2.6 Pfizer Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Corporation Information
        11.3.2 Johnson & Johnson Overview
        11.3.3 Johnson & Johnson Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.3.4 Johnson & Johnson Anti-Hypertensive Drugs Products and Services
        11.3.5 Johnson & Johnson Anti-Hypertensive Drugs SWOT Analysis
        11.3.6 Johnson & Johnson Recent Developments
    11.4 Sanofi
        11.4.1 Sanofi Corporation Information
        11.4.2 Sanofi Overview
        11.4.3 Sanofi Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.4.4 Sanofi Anti-Hypertensive Drugs Products and Services
        11.4.5 Sanofi Anti-Hypertensive Drugs SWOT Analysis
        11.4.6 Sanofi Recent Developments
    11.5 Lupin
        11.5.1 Lupin Corporation Information
        11.5.2 Lupin Overview
        11.5.3 Lupin Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.5.4 Lupin Anti-Hypertensive Drugs Products and Services
        11.5.5 Lupin Anti-Hypertensive Drugs SWOT Analysis
        11.5.6 Lupin Recent Developments
    11.6 Ranbaxy Laboratories
        11.6.1 Ranbaxy Laboratories Corporation Information
        11.6.2 Ranbaxy Laboratories Overview
        11.6.3 Ranbaxy Laboratories Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Products and Services
        11.6.5 Ranbaxy Laboratories Anti-Hypertensive Drugs SWOT Analysis
        11.6.6 Ranbaxy Laboratories Recent Developments
    11.7 Merck
        11.7.1 Merck Corporation Information
        11.7.2 Merck Overview
        11.7.3 Merck Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.7.4 Merck Anti-Hypertensive Drugs Products and Services
        11.7.5 Merck Anti-Hypertensive Drugs SWOT Analysis
        11.7.6 Merck Recent Developments
    11.8 AstraZeneca
        11.8.1 AstraZeneca Corporation Information
        11.8.2 AstraZeneca Overview
        11.8.3 AstraZeneca Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.8.4 AstraZeneca Anti-Hypertensive Drugs Products and Services
        11.8.5 AstraZeneca Anti-Hypertensive Drugs SWOT Analysis
        11.8.6 AstraZeneca Recent Developments
    11.9 Daiichi Sankyo Company Limited
        11.9.1 Daiichi Sankyo Company Limited Corporation Information
        11.9.2 Daiichi Sankyo Company Limited Overview
        11.9.3 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Products and Services
        11.9.5 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs SWOT Analysis
        11.9.6 Daiichi Sankyo Company Limited Recent Developments
    11.10 Takeda Pharmaceutical
        11.10.1 Takeda Pharmaceutical Corporation Information
        11.10.2 Takeda Pharmaceutical Overview
        11.10.3 Takeda Pharmaceutical Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Products and Services
        11.10.5 Takeda Pharmaceutical Anti-Hypertensive Drugs SWOT Analysis
        11.10.6 Takeda Pharmaceutical Recent Developments
12 Value Chain and Sales Channels Analysis
    12.1 Anti-Hypertensive Drugs Value Chain Analysis
    12.2 Anti-Hypertensive Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Anti-Hypertensive Drugs Production Mode & Process
    12.4 Anti-Hypertensive Drugs Sales and Marketing
        12.4.1 Anti-Hypertensive Drugs Sales Channels
        12.4.2 Anti-Hypertensive Drugs Distributors
    12.5 Anti-Hypertensive Drugs Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Figures, Tables and Charts Available in Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

List of Tables
    Table 1. Global Anti-Hypertensive Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Diuretics
    Table 3. Major Manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors
    Table 4. Major Manufacturers of Angiotensin Receptor Blockers (ARBs)
    Table 5. Major Manufacturers of Calcium Channel Blockers
    Table 6. Major Manufacturers of Beta Blockers
    Table 7. Major Manufacturers of Alpha Blockers
    Table 8. Major Manufacturers of Vasodilators
    Table 9. Major Manufacturers of Renin Inhibitors
    Table 10. Global Anti-Hypertensive Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Anti-Hypertensive Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 12. Global Anti-Hypertensive Drugs Sales by Region (2017-2022) & (K Units)
    Table 13. Global Anti-Hypertensive Drugs Sales Market Share by Region (2017-2022)
    Table 14. Global Anti-Hypertensive Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Anti-Hypertensive Drugs Revenue Market Share by Region (2017-2022)
    Table 16. Global Anti-Hypertensive Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 17. Global Anti-Hypertensive Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 18. Global Anti-Hypertensive Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 19. Global Anti-Hypertensive Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 20. Top Anti-Hypertensive Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
    Table 21. Anti-Hypertensive Drugs Market Trends
    Table 22. Anti-Hypertensive Drugs Market Drivers
    Table 23. Anti-Hypertensive Drugs Market Challenges
    Table 24. Anti-Hypertensive Drugs Market Restraints
    Table 25. Global Anti-Hypertensive Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 26. Global Anti-Hypertensive Drugs Sales Share by Manufacturers (2017-2022)
    Table 27. Global Anti-Hypertensive Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 28. Ranking of Global Top Anti-Hypertensive Drugs Manufacturers by Revenue (US$ Million) in 2021
    Table 29. Anti-Hypertensive Drugs Revenue Share by Manufacturers (2017-2022)
    Table 30. Global Anti-Hypertensive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Hypertensive Drugs as of 2021)
    Table 32. Key Manufacturers Anti-Hypertensive Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Pcs)
    Table 33. Key Manufacturers Anti-Hypertensive Drugs Plants/Factories Distribution
    Table 34. Key Manufacturers Anti-Hypertensive Drugs Area Served
    Table 35. Date of Key Manufacturers Enter into Anti-Hypertensive Drugs Market
    Table 36. Key Manufacturers Anti-Hypertensive Drugs Product Type
    Table 37. Mergers & Acquisitions, Expansion Plans
    Table 38. Global Anti-Hypertensive Drugs Sales (K Units) by Type (2017-2022)
    Table 39. Global Anti-Hypertensive Drugs Sales Share by Type (2017-2022)
    Table 40. Global Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
    Table 41. Global Anti-Hypertensive Drugs Price (K Units) by Type (2017-2022)
    Table 42. Global Anti-Hypertensive Drugs Sales (K Units) by Type (2023-2028)
    Table 43. Global Anti-Hypertensive Drugs Sales Share by Type (2023-2028)
    Table 44. Global Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
    Table 45. Global Anti-Hypertensive Drugs Revenue Share by Type (2023-2028)
    Table 46. Global Anti-Hypertensive Drugs Price (K Units) by Type (2023-2028)
    Table 47. Global Anti-Hypertensive Drugs Sales (K Units) by Application (2017-2022)
    Table 48. Global Anti-Hypertensive Drugs Sales Share by Application (2017-2022)
    Table 49. Global Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
    Table 50. Global Anti-Hypertensive Drugs Price (K Units) by Application (2017-2022)
    Table 51. Global Anti-Hypertensive Drugs Sales (K Units) by Application (2023-2028)
    Table 52. Global Anti-Hypertensive Drugs Sales Share by Application (2023-2028)
    Table 53. Global Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
    Table 54. Global Anti-Hypertensive Drugs Revenue Share by Application (2023-2028)
    Table 55. Global Anti-Hypertensive Drugs Price (K Units) by Application (2023-2028)
    Table 56. North America Anti-Hypertensive Drugs Sales by Company (2017-2022) & (K Units)
    Table 57. North America Anti-Hypertensive Drugs Sales Market Share by Company (2017-2022)
    Table 58. North America Anti-Hypertensive Drugs Revenue by Company (2017-2022) & (US$ Million)
    Table 59. North America Anti-Hypertensive Drugs Revenue Market Share by Company (2017-2022)
    Table 60. North America Anti-Hypertensive Drugs Sales by Type (2017-2022) & (K Units)
    Table 61. North America Anti-Hypertensive Drugs Sales by Type (2023-2028) & (K Units)
    Table 62. North America Anti-Hypertensive Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 63. North America Anti-Hypertensive Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 64. North America Anti-Hypertensive Drugs Sales by Application (2017-2022) & (K Units)
    Table 65. North America Anti-Hypertensive Drugs Sales by Application (2023-2028) & (K Units)
    Table 66. North America Anti-Hypertensive Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 67. North America Anti-Hypertensive Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 68. North America Anti-Hypertensive Drugs Sales by Country (2017-2022) & (K Units)
    Table 69. North America Anti-Hypertensive Drugs Sales by Country (2023-2028) & (K Units)
    Table 70. North America Anti-Hypertensive Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 71. North America Anti-Hypertensive Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Europe Anti-Hypertensive Drugs Sales by Company (2017-2022) & (K Units)
    Table 73. Europe Anti-Hypertensive Drugs Sales Market Share by Company (2017-2022)
    Table 74. Europe Anti-Hypertensive Drugs Revenue by Company (2017-2022) & (US$ Million)
    Table 75. Europe Anti-Hypertensive Drugs Revenue Market Share by Company (2017-2022)
    Table 76. Europe Anti-Hypertensive Drugs Sales by Type (2017-2022) & (K Units)
    Table 77. Europe Anti-Hypertensive Drugs Sales by Type (2023-2028) & (K Units)
    Table 78. Europe Anti-Hypertensive Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 79. Europe Anti-Hypertensive Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 80. Europe Anti-Hypertensive Drugs Sales by Application (2017-2022) & (K Units)
    Table 81. Europe Anti-Hypertensive Drugs Sales by Application (2023-2028) & (K Units)
    Table 82. Europe Anti-Hypertensive Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 83. Europe Anti-Hypertensive Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 84. Europe Anti-Hypertensive Drugs Sales by Country (2017-2022) & (K Units)
    Table 85. Europe Anti-Hypertensive Drugs Sales by Country (2023-2028) & (K Units)
    Table 86. Europe Anti-Hypertensive Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 87. Europe Anti-Hypertensive Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 88. Asia Pacific Anti-Hypertensive Drugs Sales by Company (2017-2022) & (K Units)
    Table 89. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Company (2017-2022)
    Table 90. Asia Pacific Anti-Hypertensive Drugs Revenue by Company (2017-2022) & (US$ Million)
    Table 91. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Company (2017-2022)
    Table 92. Asia Pacific Anti-Hypertensive Drugs Sales by Type (2017-2022) & (K Units)
    Table 93. Asia Pacific Anti-Hypertensive Drugs Sales by Type (2023-2028) & (K Units)
    Table 94. Asia Pacific Anti-Hypertensive Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 95. Asia Pacific Anti-Hypertensive Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 96. Asia Pacific Anti-Hypertensive Drugs Sales by Application (2017-2022) & (K Units)
    Table 97. Asia Pacific Anti-Hypertensive Drugs Sales by Application (2023-2028) & (K Units)
    Table 98. Asia Pacific Anti-Hypertensive Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 99. Asia Pacific Anti-Hypertensive Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 100. Asia Pacific Anti-Hypertensive Drugs Sales by Region (2017-2022) & (K Units)
    Table 101. Asia Pacific Anti-Hypertensive Drugs Sales by Region (2023-2028) & (K Units)
    Table 102. Asia Pacific Anti-Hypertensive Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 103. Asia Pacific Anti-Hypertensive Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 104. Latin America Anti-Hypertensive Drugs Sales by Company (2017-2022) & (K Units)
    Table 105. Latin America Anti-Hypertensive Drugs Sales Market Share by Company (2017-2022)
    Table 106. Latin America Anti-Hypertensive Drugs Revenue by Company (2017-2022) & (US$ Million)
    Table 107. Latin America Anti-Hypertensive Drugs Revenue Market Share by Company (2017-2022)
    Table 108. Latin America Anti-Hypertensive Drugs Sales by Type (2017-2022) & (K Units)
    Table 109. Latin America Anti-Hypertensive Drugs Sales by Type (2023-2028) & (K Units)
    Table 110. Latin America Anti-Hypertensive Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 111. Latin America Anti-Hypertensive Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 112. Latin America Anti-Hypertensive Drugs Sales by Application (2017-2022) & (K Units)
    Table 113. Latin America Anti-Hypertensive Drugs Sales by Application (2023-2028) & (K Units)
    Table 114. Latin America Anti-Hypertensive Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 115. Latin America Anti-Hypertensive Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 116. Latin America Anti-Hypertensive Drugs Sales by Country (2017-2022) & (K Units)
    Table 117. Latin America Anti-Hypertensive Drugs Sales by Country (2023-2028) & (K Units)
    Table 118. Latin America Anti-Hypertensive Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 119. Latin America Anti-Hypertensive Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 120. Middle East and Africa Anti-Hypertensive Drugs Sales by Company (2017-2022) & (K Units)
    Table 121. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Company (2017-2022)
    Table 122. Middle East and Africa Anti-Hypertensive Drugs Revenue by Company (2017-2022) & (US$ Million)
    Table 123. Middle East and Africa Anti-Hypertensive Drugs Revenue Market Share by Company (2017-2022)
    Table 124. Middle East and Africa Anti-Hypertensive Drugs Sales by Type (2017-2022) & (K Units)
    Table 125. Middle East and Africa Anti-Hypertensive Drugs Sales by Type (2023-2028) & (K Units)
    Table 126. Middle East and Africa Anti-Hypertensive Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 127. Middle East and Africa Anti-Hypertensive Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 128. Middle East and Africa Anti-Hypertensive Drugs Sales by Application (2017-2022) & (K Units)
    Table 129. Middle East and Africa Anti-Hypertensive Drugs Sales by Application (2023-2028) & (K Units)
    Table 130. Middle East and Africa Anti-Hypertensive Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 131. Middle East and Africa Anti-Hypertensive Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 132. Middle East and Africa Anti-Hypertensive Drugs Sales by Country (2017-2022) & (K Units)
    Table 133. Middle East and Africa Anti-Hypertensive Drugs Sales by Country (2023-2028) & (K Units)
    Table 134. Middle East and Africa Anti-Hypertensive Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 135. Middle East and Africa Anti-Hypertensive Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 136. Novartis Corporation Information
    Table 137. Novartis Description and Overview
    Table 138. Novartis Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 139. Novartis Anti-Hypertensive Drugs Product and Services
    Table 140. Novartis Anti-Hypertensive Drugs SWOT Analysis
    Table 141. Novartis Recent Developments
    Table 142. Pfizer Corporation Information
    Table 143. Pfizer Description and Overview
    Table 144. Pfizer Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 145. Pfizer Anti-Hypertensive Drugs Product and Services
    Table 146. Pfizer Anti-Hypertensive Drugs SWOT Analysis
    Table 147. Pfizer Recent Developments
    Table 148. Johnson & Johnson Corporation Information
    Table 149. Johnson & Johnson Description and Overview
    Table 150. Johnson & Johnson Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 151. Johnson & Johnson Anti-Hypertensive Drugs Product and Services
    Table 152. Johnson & Johnson Anti-Hypertensive Drugs SWOT Analysis
    Table 153. Johnson & Johnson Recent Developments
    Table 154. Sanofi Corporation Information
    Table 155. Sanofi Description and Overview
    Table 156. Sanofi Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 157. Sanofi Anti-Hypertensive Drugs Product and Services
    Table 158. Sanofi Anti-Hypertensive Drugs  SWOT Analysis
    Table 159. Sanofi Recent Developments
    Table 160. Lupin Corporation Information
    Table 161. Lupin Description and Overview
    Table 162. Lupin Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 163. Lupin Anti-Hypertensive Drugs Product and Services
    Table 164. Lupin Anti-Hypertensive Drugs SWOT Analysis
    Table 165. Lupin Recent Developments
    Table 166. Ranbaxy Laboratories Corporation Information
    Table 167. Ranbaxy Laboratories Description and Overview
    Table 168. Ranbaxy Laboratories Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 169. Ranbaxy Laboratories Anti-Hypertensive Drugs Product and Services
    Table 170. Ranbaxy Laboratories Anti-Hypertensive Drugs SWOT Analysis
    Table 171. Ranbaxy Laboratories Recent Developments
    Table 172. Merck Corporation Information
    Table 173. Merck Description and Overview
    Table 174. Merck Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 175. Merck Anti-Hypertensive Drugs Product and Services
    Table 176. Merck Anti-Hypertensive Drugs SWOT Analysis
    Table 177. Merck Recent Developments
    Table 178. AstraZeneca Corporation Information
    Table 179. AstraZeneca Description and Overview
    Table 180. AstraZeneca Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 181. AstraZeneca Anti-Hypertensive Drugs Product and Services
    Table 182. AstraZeneca Anti-Hypertensive Drugs SWOT Analysis
    Table 183. AstraZeneca Recent Developments
    Table 184. Daiichi Sankyo Company Limited Corporation Information
    Table 185. Daiichi Sankyo Company Limited Description and Overview
    Table 186. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 187. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product and Services
    Table 188. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs SWOT Analysis
    Table 189. Daiichi Sankyo Company Limited Recent Developments
    Table 190. Takeda Pharmaceutical Corporation Information
    Table 191. Takeda Pharmaceutical Description and Overview
    Table 192. Takeda Pharmaceutical Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
    Table 193. Takeda Pharmaceutical Anti-Hypertensive Drugs Product and Services
    Table 194. Takeda Pharmaceutical Anti-Hypertensive Drugs SWOT Analysis
    Table 195. Takeda Pharmaceutical Recent Developments
    Table 196. Key Raw Materials Lists
    Table 197. Raw Materials Key Suppliers Lists
    Table 198. Anti-Hypertensive Drugs Distributors List
    Table 199. Anti-Hypertensive Drugs Customers List
    Table 200. Research Programs/Design for This Report
    Table 201. Key Data Information from Secondary Sources
    Table 202. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Hypertensive Drugs Product Picture
    Figure 2. Global Anti-Hypertensive Drugs Sales Market Share by Type in 2021 & 2028
    Figure 3. Diuretics Product Picture
    Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture
    Figure 5. Angiotensin Receptor Blockers (ARBs) Product Picture
    Figure 6. Calcium Channel Blockers Product Picture
    Figure 7. Beta Blockers Product Picture
    Figure 8. Alpha Blockers Product Picture
    Figure 9. Vasodilators Product Picture
    Figure 10. Renin Inhibitors Product Picture
    Figure 11. Global Anti-Hypertensive Drugs Sales Market Share by Application in 2021 & 2028
    Figure 12. Hospital Pharmacies Use Case
    Figure 13. Retail Pharmacies Use Case
    Figure 14. Online Pharmacies Use Case
    Figure 15. Anti-Hypertensive Drugs Report Years Considered
    Figure 16. Global Anti-Hypertensive Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Anti-Hypertensive Drugs Market Size 2017-2028 (US$ Million)
    Figure 18. Global Anti-Hypertensive Drugs Sales (2017-2022) & (K Units)
    Figure 19. Global Anti-Hypertensive Drugs Market Size Market Share by Region: 2021 VS 2028
    Figure 20. Global Anti-Hypertensive Drugs Sales Market Share by Region (2017-2022)
    Figure 21. Global Anti-Hypertensive Drugs Sales Market Share by Region in 2021
    Figure 22. Global Anti-Hypertensive Drugs Revenue Market Share by Region in 2017 VS 2021
    Figure 23. Global Anti-Hypertensive Drugs Sales Share by Manufacturers in 2021
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Hypertensive Drugs Sales in 2021
    Figure 25. Anti-Hypertensive Drugs Revenue Share by Manufacturers in 2021
    Figure 26. Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 27. Global Anti-Hypertensive Drugs Revenue Share by Type (2017-2022)
    Figure 28. Global Anti-Hypertensive Drugs Revenue Growth Rate by Type in 2017 & 2021
    Figure 29. Global Anti-Hypertensive Drugs Revenue Share by Application (2017-2022)
    Figure 30. Global Anti-Hypertensive Drugs Revenue Growth Rate by Application in 2017 & 2021
    Figure 31. North America Anti-Hypertensive Drugs Sales Market Share by Type (2017-2028)
    Figure 32. North America Anti-Hypertensive Drugs Revenue Market Share by Type (2017-2028)
    Figure 33. North America Anti-Hypertensive Drugs Sales Market Share by Application (2017-2028)
    Figure 34. North America Anti-Hypertensive Drugs Revenue Market Share by Application (2017-2028)
    Figure 35. North America Anti-Hypertensive Drugs Sales Share by Country (2017-2028)
    Figure 36. North America Anti-Hypertensive Drugs Revenue Share by Country (2017-2028)
    Figure 37. U.S. Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 38. Canada Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 39. Europe Anti-Hypertensive Drugs Sales Market Share by Type (2017-2028)
    Figure 40. Europe Anti-Hypertensive Drugs Revenue Market Share by Type (2017-2028)
    Figure 41. Europe Anti-Hypertensive Drugs Sales Market Share by Application (2017-2028)
    Figure 42. Europe Anti-Hypertensive Drugs Revenue Market Share by Application (2017-2028)
    Figure 43. Europe Anti-Hypertensive Drugs Sales Share by Country (2017-2028)
    Figure 44. Europe Anti-Hypertensive Drugs Revenue Share by Country (2017-2028)
    Figure 45. Germany Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 46. France Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 47. U.K. Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. Italy Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. Russia Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Type (2017-2028)
    Figure 51. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Application (2017-2028)
    Figure 53. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Anti-Hypertensive Drugs Sales Share by Region (2017-2028)
    Figure 55. Asia Pacific Anti-Hypertensive Drugs Revenue Share by Region (2017-2028)
    Figure 56. China Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 57. Japan Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 58. South Korea Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. India Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. Australia Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. Taiwan Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Indonesia Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Thailand Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Malaysia Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Philippines Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Vietnam Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Anti-Hypertensive Drugs Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Anti-Hypertensive Drugs Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Anti-Hypertensive Drugs Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Anti-Hypertensive Drugs Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Anti-Hypertensive Drugs Sales Share by Country (2017-2028)
    Figure 72. Latin America Anti-Hypertensive Drugs Revenue Share by Country (2017-2028)
    Figure 73. Mexico Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Anti-Hypertensive Drugs Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Anti-Hypertensive Drugs Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Anti-Hypertensive Drugs Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Anti-Hypertensive Drugs Revenue Share by Country (2017-2028)
    Figure 82. Turkey Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Anti-Hypertensive Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. Anti-Hypertensive Drugs Value Chain
    Figure 86. Anti-Hypertensive Drugs Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed

Keyplayers in Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical

Request Sample

Pre-order Enquiry

Request Discount

Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Detailed TOC of Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

List of Figures, Tables and Charts Available in Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Keyplayers in Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Our Clients